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Non-O157 Shiga toxin-producing Escherichia coli (STEC) are foodborne pathogens of growing concernworldwide
that have been associatedwith several recent multistate andmultinational outbreaks of foodborne illness. Rapid
and sensitive molecular-based bacterial strain discrimination methods are critical for timely outbreak identifica-
tion and contaminated food source traceback. One suchmethod, multiple-locus variable-number tandem repeat
analysis (MLVA), is being usedwith increasing frequency in foodborne illness outbreak investigations to augment
the current gold standard bacterial subtyping technique, pulsed-field gel electrophoresis (PFGE). The objective of
this studywas to develop aMLVA assay for intra- and inter-serogroup discrimination of sixmajor non-O157 STEC
serogroups—O26, O111, O103, O121, O45, and O145—and perform a preliminary internal validation of themeth-
od on a limited number of clinical isolates. The resultant MLVA scheme consists of ten variable number tandem
repeat (VNTR) loci amplified in three multiplex PCR reactions. Sixty-five unique MLVA types were obtained
among 84 clinical non-O157 STEC strains comprised of geographically diverse sporadic and outbreak related
isolates. Compared to PFGE, the developed MLVA scheme allowed similar discrimination among serogroups
O26, O111, O103, and O121 but not among O145 and O45. To more fully compare the discriminatory power of
this preliminary MLVA method to PFGE and to determine its epidemiological congruence, a thorough internal
and external validation needs to be performed on a carefully selected large panel of strains, including multiple
isolates from single outbreaks.
© 2016 Elsevier B.V. All rights reserved.
Keywords:
Escherichia coli O157
Non-O157 STEC
MLVA
Strain discrimination
Outbreak investigation
1. Introduction
Escherichia coli is a genetically diverse enteric bacterial species that is
an essential constituent of the natural gut micro flora of many warm-
blooded organisms. Most E. coli strains are commensal, but some are
pathogenic to humans. The most severe and life-threatening human
illness caused by E. coli, hemolytic uremic syndrome (HUS), is associat-
ed with the production of one or more Shiga toxins and expression of a
few other virulence determinants (O'Brien et al., 1992; Ethelberg et al.,
2004; Gyles, 2007; Besser et al., 1999; Tarr et al., 2005). Of over 100
Shiga toxin-producing E. coli (STEC) serogroups identified by the
World Health Organization, O157 is the most commonly isolated
serogroup in the United States and causes the highest percentage of ill-
nesses (Scallan et al., 2011; Johnson et al., 1996; CDC, 2012). However,
non-O157 STEC serogroups have been increasingly associated with
human illness in recent years and have caused several major outbreaks
(Brooks et al., 2005; Johnson et al., 2006; Bettelheim, 2007). Non-O157
STEC serogroups O26, O111, O103, O121, O45, and O145 are the most
frequently isolated in the United States and are often referred to as
the ‘big 6’ non-O157 STEC serogroups (Karmali et al., 2003).
Molecular bacterial subtyping methods are essential tools in
outbreak investigations involving STEC, from the initial identification
of clusters of foodborne illness, the outbreak investigation process,
and while monitoring the effectiveness of product recalls. The PulseNet
network coordinated by the United States Centers for Disease Control
and Prevention (CDC) and the Association of Public Health Laboratories
(APHL) is the national molecular subtyping network that functions as a
foodborne illness cluster detection tool. The primary bacterial subtyping
method used by PulseNet is pulsed-field gel electrophoresis (PFGE),
the current gold standard bacterial subtyping method for foodborne
pathogens (Swaminathan et al., 2001). Although the good epidemiolog-
ical congruence and high bacterial strain discriminatory capability of
PFGE are well documented by the success of the PulseNet network,
the technique has several drawbacks. PFGE is a time-consuming and la-
borious method requiring a high level of technical skill and rigorous
standardization to allow inter-laboratory data sharing. Additionally,
in some cases PFGE does not allow optimal discrimination among closely
related bacterial isolates (Hyytiä-Trees et al., 2006). To overcome these
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limitations, PulseNet has begun to augment PFGEdata of outbreak-related
bacterial isolates with DNA sequence- and PCR-based methods.
Multiple-locus variable-number tandem repeat analysis (MLVA) is a
molecular subtypingmethod based on detection of differing numbers of
tandem repeats within several distinct variable-number tandem repeat
(VNTR) loci throughout a bacterial genome (Keim et al., 2000). Follow-
ing PCR amplification of VNTR loci, the amplified DNA fragments are
sized or sequenced and compared among different strains. The tandem
repeat copy number of each VNTR locus can be designated as a discrete
allele type denoted by an integer corresponding to the number of tan-
dem repeats at a given locus, with the string of allele types for several
VNTR loci constituting a MLVA type, allowing data comparison among
multiple laboratories over extended periods of time (Hyytiä-Trees
et al., 2006). MLVA is currently used by PulseNet to help discriminate
among highly clonal isolates of Salmonella Typhimurium DT104
(Lindstedt et al., 2003; Lindstedt et al., 2004), Salmonella Enteritidis
(Cho et al., 2007; Boxrud et al., 2007), and O157 STEC (Hyytiä-Trees
et al., 2010).
The current O157 STEC MLVA protocol used by PulseNet (Hyytiä-
Trees et al., 2010), an optimized and modified 8-locus version of the
MLVA method developed by Keys et al. (2005), has proven to be useful
in outbreak investigations, allowing a high level of discrimination in
conjunction with PFGE. However, this protocol was developed specifi-
cally for O157 STEC and PCR amplification of many of the VNTR loci is
not possible in non-O157 STEC serogroups (Izumiya et al., 2010;
Lindstedt et al., 2007). Given the increasing isolation rates of non-
O157 STEC, a MLVA method optimized for these pathogens is needed.
However, most MLVA methods target a single serogroup or serotype
and development of a MLVA method targeting multiple serogroups
poses notable challenges (Karama and Gyles, 2010). The discriminatory
power at the serotype level is likely to be decreased ifmultiple serogroups
are targeted in a single protocol since loci conserved enough to be present
in multiple serotypes might not provide the necessary level of dis-
crimination. In addition, the most diverse loci and slight differences
in VNTR locus flanking sequences among several serogroups can
make optimal PCR primer design difficult. As a result, maximum
strain discrimination may necessitate individual MLVA protocols
for each serogroup. However, a single MLVA protocol for multiple
serogroups would be more practical in public health laboratories
and the difficulties associated with developing such a protocol can
be overcome.
Two notable MLVA schemes for multiple E. coli serogroups have
been recently developed and used to subtype non-O157 STEC
(Løbersli et al., 2012; Izumiya et al., 2010). The MLVA scheme by
Løbersli et al. (2012) was originally designed to discriminate among
all E. coli serogroups (not just STEC), validated by typing the E. coli refer-
ence (ECOR) collection (Lindstedt et al., 2007), and subsequently opti-
mized by discarding the least informative loci and adding two VNTR
loci and one CRISPR (clustered regularly interspaced short palindromic
repeat) locus (Løbersli et al., 2012). The MLVA scheme by Izumiya et al.
(2010) was designed to target STEC serogroups O157, O111, and O26,
essentially by adding nine VNTR loci to the O157-specific MLVA proto-
col developed by Hyytiä-Trees et al. (2006). Although both of these
MLVA schemes have been found to be useful in outbreak investigations,
when targeting the ‘big 6’ non-O157 STEC serogroups, the scheme by
Izumiya et al. (2010) may be too narrow while the scheme developed
by Løbersli et al. (2012) may be too broad. By searching for diverse
VNTR loci present in the seven currently available and fully-assembled
‘big-6’ non-O157 STEC genomes in GeneBank, it may be possible to de-
velop a novelMLVA scheme that allows increased discrimination for the
‘big 6’ non-O157 STEC. Of the above mentioned E. coli MLVA schemes,
only Izumiya et al. (2010) used assembled non-O157 STEC genomes
(O26 and O111) in addition to four O157:H7 STEC genomes for identify-
ing potentially discriminatory VNTR loci. Thus, the objective of this study
was to develop a robust and highly discriminatoryMLVA scheme primar-
ily for the six major non-O157 STEC serogroups—O26, O111, O103, O121,
O45, and O145—by independently identifying diverse and informative
VNTR loci from seven assembled non-O157 STEC genomes (O26(1),
O111(1), O103(1), and O145(4)). The concordance of the MLVA data
with PFGE data is presented and the MLVA assay was also used to type
O157 STEC, generic E. coli, and enteropathogenic E. coli for comparison.
2. Materials and methods
2.1. Bacterial strains
A total of 92 E. coli strainswere used in this study. Initial assay devel-
opment and optimization was done with 24 non-O157 STEC strains
Table 1
Twenty-four human isolates of the non-O157 STEC reference set.a
O H Isolate ID Isolation location Isolation date Clinical manifestation MLVA patternb
26 11 DEC10B Australia 1986 Diarrhea (bloody) 046
26 11 97-3250 USA (Idaho) 1997 HUS (expired) 047
26 MT#10 USA (Mont.) 1999–2000 048
26 N TB352A USA (Wash.) 1991 Diarrhea (chronic) 049
45 2 M103-19 USA (Mich.) 2003 050
45 2 MI01-88 USA (Mich.) 2001 027
45 2 MI05-14 USA (Mich.) 2006 025
45 NM DA-21 USA (Fla.) 1999 Diarrhea (bloody) 027
103 2 MT#80 USA (Mont.) 1999–2000 051
103 6 TB154A USA (Wash.) 1991 Diarrhea 052
103 25 8419 USA (Idaho) 053
103 N PT91-24 USA (Wash.) 1990 054
111 2 RD8 France 1992 HUS (outbreak) 055
111 8 3215-99 USA (TX) 1999 HC (outbreak) 056
111 11 0201 9611 USA (Conn.) 2003 057
111 NM 3007-85 USA (Neb.) 1985 058
121 19 MDCH-4 USA (Mich.) 2000 059
121 19 MT#2 USA (Mont.) 1998 060
121 MT#18 USA (Mont.) 1999–2000 061
121 [19] DA-5 USA (Mass.) 1998 Diarrhea (bloody) 062
145 16 DEC10I Canada 1987 HC (HUS) 063
145 [28] 4865/96 Germany 1996 HUS 064
145 NM GS G5578620 USA (Neb.) 1998 Diarrhea 064
145 NT IH 16 Uruguay 065
a MLVA pattern designations were determined in this study.
b Information provided by the STEC Center of Michigan State University.
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obtained from the STEC Center at Michigan State University (MSU) as
part of a non-O157 STEC reference set. This set includes four individual
strains of each of the six major non-O157 STEC serogroups (O26, O103,
O111, O121, O145, andO45) isolated from humans in Australia, Canada,
France, Germany, Uruguay, and theUnited States over a span of 20 years
(Table 1). Preliminary validation was carried out with 60 non-O157
STEC isolates obtained from the Enteric Disease Laboratory Branch at
the CDC (ten strains from each of the six non-O157 serogroups;
Fig. 2). Fifty-eight out of 60 strains were clinical isolates associated
with either outbreaks or sporadic cases (Table 2); two were of animal
origin. Epidemiological information and PFGE data for all 60 isolates
was provided by the CDC (Fig. 2). In addition to the 84 non-O157
STEC isolates, five isolates of STEC O157:H7, two isolates of entero-
pathogenic E. coli, and one strain of E. coli K-12 were also analyzed for
comparison (Table 3).
2.2. VNTR locus selection
To identify potentially useful VNTR loci for inter- and intra-
serogroup discrimination of non-O157 STEC, the published genomes
of E. coli O26:H11 strain 11368 (NC_013361.1), E. coli O103:H2 strain
12009 (NC_013353.1), E. coli O111:H-strain 11128 (NC_013364.1),
Table 2
Sixty non-O157 STEC isolates from CDC.
Serogroup Isolate ID State Serotype Epidemiological information XbaI patterna BlnI pattern MLVA pattern
O145 2010C-3517 MI O145:NM Cluster 1004MIENM-1 ENMX01.0025 ENMA26.0018 001
2010C-3515 MI O145:NM Cluster 1004MIENM-1 ENMX01.0016 ENMA26.0017 001
2010C-3507 OH O145:NM Cluster 1004MIENM-1 ENMX01.0016 ENMA26.0017 001
2010C-3508 OH O145:NM Cluster 1004MIENM-1 ENMX01.0016 ENMA26.0017 002
2010C-3513 MI O145:NM Cluster 1004MIENM-1 ENMX01.0016 ENMA26.0017 001
2010C-3526 MI O145:NM Cluster 1004MIENM-1 ENMX01.0043 ENMA26.0018 001
K6208 ND O145:NM Sporadic isolate ENMX01. 003
2011EL-1210 FL O145:NM Sporadic isolate ENMX01.0112 ENMA26.0085 004
3060-04 UT O145:NM Sporadic isolate ENMX01.0082 005
K2387 MD O145:NM Sporadic isolate ENMX01.0040 006
O111 K6807 OK O111:NM Cluster 0808OKEXD-1 EXDX01.0005 EXDA26.0029 007
K6808 OK O111:NM Cluster 0808OKEXD-1 EXDX01.0005 EXDA26.0029 008
K6809 OK O111:NM Cluster 0808OKEXD-1 EXDX01.0005 EXDA26.0029 007
K7091 OK O111:H8 Cluster 0808OKEXD-1 EXDX01.0005 EXDA26.0029 007
K5652 IN O111:NM Sporadic isolate EXDX01. 009
2009EL1340 FL O111:NM Sporadic isolate EXDX01. 010
2010EL-1239 CO O111:NM Cluster 1005COEXD-1 EXDX01.0123 EXDA26.0077 011
2010EL-1240 CO O111:NM Cluster 1005COEXD-1 EXDX01.0130 EXDA26.0077 011
2010EL-2219 FL O111:H8 Sporadic isolate EXDX01. 012
2010EL-2231 FL O111:H8 Sporadic isolate EXDX01. 013
O26 2009EL-1049 OK O26:H11 Sporadic isolate EVCX01.0260 014
2011EL-1012 IN O26:H9 Sporadic isolate EVCX01.0103 015
2011EL-1138 AK O26:H11 Sporadic isolate EVCX01.0383 016
2010EL-1372 WA O26:NM Daycare outbreak EVCX01.0264 017
2009EL-1480 FL O26:H11 Sporadic isolate EVCX01. 018
2011EL-1233 NV O26:H11 Sporadic isolate EVCX01.0071 EVCA26.0236 019
2010EL-2220 FL O26:H11 Sporadic isolate EVCX01.0930 020
K3621 CO O26:H11 Sporadic isolate EVCX01. 021
K3651 NC O26:H11 Sporadic isolate EVCX01. 022
K5537 MO O26:H11 Sporadic isolate EVCX01. 023
O45 05-3031 UT O45:H2 Sporadic isolate EH2X01.0003 024
03-3300 MO O45:H2 Sporadic isolate EH2X01. 024
K3472 NC O45:H2 Sporadic isolate EH2X01.0031 EH2A26.0023 025
K3523 FL O45:H2 Sporadic isolate EH2X01. 026
3506-04 MI O45:H2 Sporadic isolate EH2X01.0031 EH2A26.0023 027
3001-04 MO O45:H2 Sporadic isolate EH2X01.0008 027
3065-04 WI O45:H2 Sporadic isolate EH2X01. 028
3093-04 MA O45:H2 Sporadic isolate EH2X01.0021 027
3095-04 MA O45:H2 Sporadic isolate EH2X01. 025
3105-04 MI O45:H2 Sporadic isolate EH2X01.0066 026
O103 2009EL1342 FL O103:NM Sporadic isolate EXWX01.0537 029
2009EL1295 IN O103:H2 Sporadic isolate EXWX01.0540 030
3546-05 VA O103:H25 Sporadic isolate EXWX01.0146 031
3409-05 VA O103:H25 Sporadic isolate EXWX01.0145 032
K3530 NE O103:H2 Goat associated EXWX01. 033
K3529 NE O103:H2 Goat associated EXWX01. 034
K3435 MO O103:H2 Sporadic isolate EXWX01. 035
2010C-3251 IA O103:H2 Sporadic isolate EXWX01.0128 EXWA26.0034 036
2010C-3219 IA O103:H2 Sporadic isolate EXWX01.0128 EXWA26.0034 036
2009EL-1899 FL O103:H2 Sporadic isolate EXWX01.0073 EXWA26.0048 037
O121 K5363 CT O121:H19 Sporadic isolate EXKX01. 038
K5316 CO O121:H19 Sporadic isolate EXKX01.0001 EXKA26.0001 039
K5313 CO O121:H19 Cluster 0707COEXK-1 EXKX01.0001 EXKA26.0001 039
K5223 CO O121:H19 Cluster 0707COEXK-1 EXKX01.0011 EXKA26.0001 039
K3673 FL O121:H19 Sporadic isolate EXKX01. 040
K3663 CO O121:H19 Sporadic isolate EXKX01.0074 041
K2126 VT O121:H19 Sporadic isolate EXKX01.0041 042
3294-06 WY O121:H19 Sporadic isolate EXKX01.0011 EXKA26.0001 043
3326-06 NY O121:H19 Sporadic isolate EXKX01. 044
K2225 FL O121:H19 Sporadic isolate EXKX01.0044 045
a New unique patterns were not named in the PFGE database which explains the incomplete pattern names.
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E. coli O145:H28 strain RM12581 (CP007136.1), E. coli O145:H28 strain
RM13514 (CP006027.1), E. coli O145:H28 strain RM13516 (CP006262.1),
and E. coliO145:H28 strainRM12761 (CP007133.1)were scanned for tan-
dem repeats using the Tandem Repeats Finder software (Benson, 1999).
Custom parameters were chosen for Tandem Repeats Finder to narrow
the number of reported tandem repeat arrays to those comprised of
between 4 and 20 bp repeats, with larger tandem repeat copy numbers,
and minimal mismatching and indels within the tandem repeat array
(Nadon et al., 2013). Once candidate VNTR loci were identified, the
flanking sequences of the repeat arrays were searched against NCBI's
whole genome shotgun contigs (wgs) database with BLAST since several
other non-O157 STEC genomes (in addition to the seven listed above)
have been sequenced but not fully assembled.
In accordance with Nadon et al. (2013), selection of a VNTR locus
was based on several criteria: a locus had to be present in at least two
of the three assembled genomes, had to have a high number of tandem
repeat percent matches (N80%), and had to have a low percentage of
indels (b3%). These criteria ensured selection of conserved but diverse
VNTR loci with common tandem repeat consensus sequences. Follow-
ing initial selection of possible loci, the flanking sequences of each of
the VNTR loci were aligned with ClustalW (Larkin et al., 2007). Only
VNTR loci having highly similar flanking sequences were selected to
allow optimal primer design and minimize the need for degenerate
primers. Additionally, VNTR loci exhibiting differences in tandem repeat
copy numbers among the three strainswere preferentially selected. The
more diverse but often less conserved loci (larger difference in copy
number)were selected to help discriminate closely related strainswith-
in individual serogroups while the less diverse andmore conserved loci
(smaller difference in copy number) were selected to help discriminate
among different serogroups (Keys et al., 2005). The final selection in-
cluded ten VNTR loci, seven of which have been previously described
butwere renamed for the sake of uniformity and due to newPCR primer
design (Table 4).
The presence and diversity of the selected loci in STEC O157:H7
strains were evaluated also by comparing each selected VNTR locus
with the Tandem Repeats Finder results of the published genomes of
Table 3
E. coli isolates used for comparison.
E. coli group Strain Outbreak source Isolation
year/location
STEC O157:H7 K3995 Spinach outbreak isolate 2006/California
C7927 Apple cider outbreak isolate 1991/Massachusetts
F4546 Alfalfa sprout outbreak isolate 1997/Michigan
EO144 Meat isolate
SEA-13B88 Apple juice outbreak isolate
EPEC O119:H6
O55:H6
Non-pathogenic K-12
Table 4
Characteristics of the ten VNTR loci used in this study.
Locus
name
Alternativea
name
Array location (5′ end) Repeat
length (nt)
Consensus
sequence
Primers (5′-3′) Primer
Tm (°C)
Offset
size (nt)
Primer
conc. (μM)
Function
SVL-1 O157-2, EHC-2,
CVN016
250070 in O111 6 CTCTGA F: 6FAM-ACTGTTTC
AGCGGTCTCTTCC
60.81 97 0.05 Putative ATP-dependent Clp
proteinase ATP-binding
chainR: ACG CAG ATA CCG
TGG AG
61.65
SVL-2 O157-9, Vhec4,
TR1, CVN017
2913106 in O111 6 AGAAAT F: PET-ATCGCCTTCT
TCCTCCGTAA
61.08 244 0.05 Hypothetical protein
R: TCAGGAATGTGG
TGGTCTGT
58.94
SVL-3 O157-11,
EHC-1, CVN014
4662685 in O111 6 GGTGCA F: VIC-TGGCAAACAG
CACTACCATC
59.72 248 0.04 Predicted protoheme IX
synthesis protein HemY
R: GGACCAGTTAAG
CCAGCAAA
60.25
SVL-4 CVN004 810131 in O103 15 GCAGCAAA
AGCCGCA
F: PET-GGAAGAAGCA
GCGAAGAAAG
59.34 270 0.06 Membrane anchored protein
TolA in TolA-TolQ-TolR
complexR: CATCGGGTGCCAGT
TTTATG
61.27
SVL-5 3051096 in O103 6 GCGCTG F: VIC-GTCGTCTGTG
GGATGCTCAA
62.27 159 0.05 Hydrogenase 4, Membrane
subunit HyfF
R: CAGCAATAACAG
CAGGACGA
60.01
SVL-6 2922513 in O103 9 CAGTGC
AGC
F: 6FAM-AATTAGGA
AAAGCATCAGCCG
60.57 242 0.07 Putative adenine methylase,
Putative integrase, stx2
converting phageR: CCTCCCATCGTTTC
TGTTTCC
62.98
SVL-10 EH111-14 3346927 in O111 7 TCAAAGA F: VIC-TTTGATGCAA
TGGTGGAGTG
60.52 166 0.05 Putative integrase
R: CACAAAGTGAGA
GTCCGAAAA
57.99
SVL-11 O157-37 35162 in O111 plasmid 3 6 CTGCTA F: NED-ATTCTGCTGT
GGGCTTCTGT
59.87 90 0.05 Plasmid located, no known
function
R: AATCAGAGCGGC
AGGAAAA
60.87
SVL-12 EHC-6 52289 in O26 plasmid 2 9 AACAGC
CGC
F: NED-CCGCAAGGGA
AGCAGAAG
62.02 197 0.04 Plasmid located, no known
function
R: TGCTGTTCCATCTC
TTCTTCC
59.42
SVL-23 63087 in O121:H19 str.
MT#2 EC1660_contig_31
6 TCTCCC F: PET-AAATCGGGCG
GGAAGAAG
62.38 361 0.05 Dihydrodipicolinate
synthase DapA
R: GGGCGTAAAAAG
CAATAAAGG
59.98
a O157-x loci are from Keys et al. (2005); EHC-x and EH111-x loci are from Izumiya et al. (2010); CVN0xx loci are from Løbersli et al. (2012); Vhecx loci are from Lindstedt et al. (2003);
TR loci are from Noller et al. (2003).
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four STEC O157:H7 strains (EDL933 (NC_002655.2), Sakai (NC_002695.
1), EC4115 (NC_011353.1), and TW14359 (NC_013008.1)). All loci ex-
cept SVL-10 and SVL-12 were present also in STEC O157:H7 but with
less flanking sequence similarity.
2.3. DNA preparation
Bacterial strains were grown overnight at 37 °C on trypticase soy
agar (TSA). Two to three colonies were suspended in 100 μL of sterile
distilled water and boiled for 10 min at 100 °C. The suspension was
cooled briefly and centrifuged at 10,000 rpm (8165 ×g) for 10 min.
The undiluted supernatantwasused as template DNA for PCR amplifica-
tion and stored at−20 °C.
2.4. Primer design and PCR amplification
PCR primers for amplification of selected VNTR loci were designed
from highly similar VNTR flanking sequences identified by multiple se-
quence alignment with ClustalW using Primer3 software (Untergrasser
et al., 2012), followed by an evaluation of primer thermodynamics using
theMfold web server (Zuker, 2003), then by a BLAST search against the
NCBI nucleotide (nr/nt) database for primer specificity analysis. PCR
primers were designed to minimize multiplex reactions and to
allow all multiplex PCRs to occur at the same thermal cycling condi-
tions. Therefore, all primers were designed with minimal 3′ self-
complementary sequences and with similar lengths, GC contents,
and melting temperatures. Primers amplifying previously identified
loci were redesigned to have characteristics similar to those of all
other primers in this study. Additionally, MultiPLX 2.1 (Kaplinski
et al., 2005) was used to evaluate the potential for primer dimer for-
mation among all ten primer sets. Since the specific size range of the
amplified fragments for each VNTR locus was unknown, all primers
were designed to allow multiplexing of any combination of primer
sets (i.e. minimal potential for primer dimer formation).
Initial screening of the amplification effectiveness of the ten primer
sets was carried out with the 24-isolate non-O157 STEC reference set
from the STEC Center at MSU and visualized by agarose gel electropho-
resis. Based on the amplicon sizes, the primer sets were combined into
three multiplex PCR reactions. Reaction 1 contained primer sets SVL-1,
SVL-3, and SVL-4, reaction 2 contained primer sets SVL-2, SVL-6, SVL-
10, and SVL-12, and reaction 3 contained primer sets SVL-5, SVL-11,
and SVL-23.
Forward PCR primers were fluorescently labeled to allow accurate
sizing by multicolor capillary electrophoresis (Table 4). Unlabeled re-
verse primers were synthesized by Integrated DNA Technologies
(Coralville, IA) and fluorescently labeled forward primers were synthe-
sized by Life Technologies (Foster City, CA). The PCR amplification con-
ditions were designed to mimic, as closely as possible, the PCR reaction
conditions and reagent concentrations currently used for MLVA by
PulseNet (Hyytiä-Trees et al., 2010). PCR amplification was performed
in final volumes of 10 μL consisting of 1.5 μL of 5× Colorless GoTaq Re-
action Buffer (Promega, Madison,WI), 0.4 μL of 50mMMgCl2 (bringing
final MgCl2 concentration to 2.0 mM), 1.0 U of GoTaq DNA Polymerase
(Promega), 0.2 mM of PCR Nucleotide Mix (Promega), and 1.0 μL of
DNA template. Primer concentrations were adjusted to allow optimal
peak heights for confident fragment size calling. The amplification con-
ditions consisted of an initial denaturation step at 95 °C for 5 min,
followed by 35 cycles of 95 °C for 30 s, 56 °C for 30 s, and 72 °C for
30 s, with a final extension step at 72 °C for 15 min with an Eppendorf
MasterCycler (ThermoFisher, Waltham, MA).
2.5. Fragment analysis
Amplified PCR productswere diluted 1:60 in sterile distilledwater. A
1.0 μL aliquot of the diluted PCR product was added to 8.6 μL of Hi-Di
Formamide (Life Technologies) and 0.4 μL of GeneScan 600LIZ size
standard (Life Technologies). PCR products were sized using an Applied
Biosystems 3730 Genetic Analyzer (Life Technologies).
2.6. Pulsed-field gel electrophoresis
PFGE was performed for all 84 non-O157 STEC isolates according to
the standardized PulseNet protocol (Ribot et al., 2006). All isolates were
analyzed using XbaI restriction enzyme (Roche Applied Science,
Indianapolis, IN). Twenty-three isolates from the CDC were also ana-
lyzed using BlnI restriction enzyme (Roche Applied Science) (Table 2).
PFGE patterns were analyzed with BioNumerics software version 5.01
(Applied Maths, Kortrijk, Belgium), uploaded to the PulseNet PFGE pat-
tern database, and named according to the standard nomenclature sys-
tem (Swaminathan et al., 2001).
2.7. Analysis of VNTR data
Fragment data were evaluated with GeneMapper software (Life
Technologies) and fragment peak tables from GeneMapper were
imported into BioNumerics (Applied Maths) for analysis. A custom
VNTR allele assignment script in BioNumerics was used to translate
fragment size data to copy numbers. Partial repeats were rounded up
or down to the closest complete tandem repeat number in accordance
with the scheme developed by Hyytiä-Trees et al. (2010). For each
locus, alleles were named according to the number of tandem repeats,
whereas null alleles, defined as no PCR amplification at a given locus,
were designated as −2.0 to differentiate between null alleles and
VNTR loci with no tandem repeats (i.e. a copy number of “0”). Null al-
leles were confirmed by singleplex PCR visualized by agarose gel elec-
trophoresis to rule out the lack of amplification due to multiplex PCR
complications. The diversity index (DI) for each locus was calculated
in BioNumerics based on Simpson's diversity index according to the for-
mula DI = 1− Σ (allelic frequency)2 (Hunter and Gaston, 1988; Weir,
1990). Dendrograms were constructed with BioNumerics using a cate-
gorical multi-state coefficient and UPGMA (unweighted pair group
method with arithmetic mean) clustering. Minimum spanning trees
were constructed with BioNumerics using the Manhattan coefficient.
Outbreak related isolates with indistinguishable PFGE patterns using
two restriction enzymeswere used to evaluate the epidemiological con-
cordance of the MLVA scheme in comparison to PFGE.
3. Results
3.1. Selection of VNTR loci
A comparison of reported short tandem repeat structures for four
STEC O157:H7 strains, two non-pathogenic E. coli strains, and seven
non-O157 STEC strains revealed more VNTR diversity among STEC
O157 than among non-O157 STEC and generic E. coli. While the total
number of reported tandem repeats were similar between STEC
O157:H7 strains and non-O157 STEC strains, about twice as many tan-
dem repeat arrays with high copy numbers were identified in STEC
O157:H7 strains than in non-O157 STEC strains (Table 5). The number
of tandem repeats having higher copy numbers among the non-O157
STEC strains was more similar to those found in two strains of generic
E. coli K-12, which have an approximately 800 Kb smaller genome.
The ten selected VNTR loci exhibited differing levels of diversity
among the genomic sequences of the seven fully assembled non-O157
STEC genomes in GenBank, as well as among the NCBI E. coliwhole ge-
nome shotgun contigs (wgs) database.
Since themajority of bacterial genomes code for proteins, it was ex-
pected thatmost VNTR arrays would be locatedwithin genes. Of the ten
selected VNTR loci evaluated, eight are located on the bacterial chromo-
some and two on plasmids. According to BLAST searches against the
NCBI nucleotide database, all chromosomal VNTR loci are locatedwithin
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sequences coding for known or putative proteins but the plasmid locat-
ed VNTR loci had no known functions (Table 4).
3.2. Evaluation of selected VNTR loci
All VNTR loci were polymorphic, ranging from 4 to 22 alleles per
locus (Table 6) and no isolates of different serogroups shared an indis-
tinguishable MLVA type. A high number of null alleles were observed
for several serogroups, especially among serogroups O45 and O121. Al-
though not ideal, null alleles were still useful for discrimination with
several loci (Tables 6 and 7). A low to moderate diversity index was ob-
served for the ten selected loci andwas similar for each of the loci when
comparing the two sets of isolates from CDC and MSU (Table 6). Only
SVL-3 had a relatively high overall diversity index of 0.895. Loci SVL-
11 and SVL-23 had very low diversity indices but were retained since
they aided in discrimination between serogroups O111 and O121, re-
spectively. Locus SVL-11was highly polymorphic onlywithin serogroup
O111, as was expected since this locus is located on a plasmid and may
be fairly specific for serogroup O111. SVL-1 was the most polymorphic
locus with 22 different alleles, but had only amoderate overall diversity
index (0.791) due to a lack of diversity in serogroups O103, O45, and
O145 (Table 6). Loci SVL-2, SVL-3, SVL-6 and SVL-11 also exhibited
high levels of polymorphism with 9, 15, 12, and 10 alleles, respectively
(Table 6).
Five STEC O157:H7 strains (C7927, EO144, F4546, K3995, and SEA-
13B88), two EPEC strains (O119 and O55), and one strain of generic
E. coli K-12 were MLVA typed with the selected loci and compared to
the MLVA types of the 84 non-O157 STEC isolates. Although all eight
strains had a unique MLVA type, PCR amplification was not possible at
most loci. Dendrograms generated by BioNumerics separated the STEC
O157:H7 isolates from all others when compared with both sets of
non-O157 STEC isolates from CDC and MSU (data not shown).
3.3. MLVA typing of 84 non-O157 STEC isolates
A total of 65 unique MLVA types were identified among the 84
non-O157 STEC isolates tested: 45 MLVA types among the 60 iso-
lates from CDC and 22 MLVA types among the 24 isolates from
MSU (3 O45 isolates from MSU were indistinguishable by MLVA
from 2 separate groups of O45 isolates from CDC). Serogroups gen-
erally clustered together in minimum spanning trees (Fig. 1). All
serogroups differed from each other by one or more tandem repeats
at three or more loci (Fig. 1).
3.3.1. O26
The highest level of discriminatory capability was achieved in
serogroup O26. All 14 isolates tested exhibited a unique MLVA type
that differed from all other O26 isolates by at least one locus. Thirteen
different alleles were observed in locus SVL-1 alone. The high level of
serogroup O26 discrimination was achieved with just four loci
(Table 7). Omitting all loci except SVL-1, SVL-2, SVL-3, and SVL-6 had
no effect on the discriminatory capability. Therefore, a STEC O26-
specific MLVA assay may be possible when loci SVL-1, SVL-2, SVL-3,
and SVL-6 are targeted. Following further evaluation of the congruence
Table 5
Comparison of genome size, number of reported tandem repeat arrays, and number of tandem repeat arrays with copy numbers greater than 5.0, according to Tandem Repeats Finder
software, for four STEC O157:H7, three non-O157 STEC, and two E. coli K-12 strains.
E. coli strain GenBank accession number Genome size (bp) Total number of tandem repeatsa Number of tandem repeats with copy number ≥ 5.0
O157:H7 EC4115 NC_011353.1 5572075 177 19
O157:H7 TW14359 NC_013008.1 5528136 174 20
O157:H7 EDL933 NZ_CP008957.1 5528445 167 17
O157:H7 Sakai NC_002695.1 5498450 159 15
O111:H-11128 NC_013364.1 5371077 126 7
O26:H11 11368 NC_013361.1 5697240 129 9
O103:H2 12009 NC_013353.1 5449314 123 6
O145:H28 RM12581 NZ_CP007136.1 5585611 148 6
O145:H28 RM13514 NZ_CP006027.1 5585613 148 6
O145:H28 RM13516 NZ_CP006262.1 5402276 135 9
O145:H28 RM12761 NZ_CP007133.1 5402281 135 9
K-12 DH10B NC_010473.1 4686137 87 9
K-12 W3110 NC_007779.1 4646332 89 9
a As reported by Tandem Repeats Finder software with default parameter settings.
Table 6
VNTR loci characteristics among 60 clinical non-O157 STEC isolates from the CDC and 24 isolates of a non-O157 STEC reference set from the STEC Center at Michigan State University.
VNTR locus
SVL-1 SVL-2 SVL-3 SVL-4 SVL-5 SVL-6 SVL-10 SVL-11 SVL-12 SVL-23
60 isolates from CDC Fragment range (nt) 112–254 253–295 276–365 387–452 135–210 255–394 175–278 105–172 210–289 405–422
No. of alleles 17 8 12 4 6 9 4 9 4 6
Null alleles (%) 0 47 0 0 0 35 28 75 55 6
Allelic range 3–26 2–8 5–20 8–12 0–7 1–17 1–16 3–14 1–10 7–10
Diversity index 0.75 0.729 0.898 0.561 0.532 0.798 0.543 0.433 0.532 0.275
24 isolates from MSU Fragment range (nt) 106–211 253–301 270–372 405–452 169–186 255–342 175–181 147–213 210–307 416–428
No. of alleles 13 7 9 4 5 8 3 4 5 4
Null alleles (%) 13 58 0 25 4 50 38 83 46 4
Allelic range 2–19 2–9 4–21 9–12 2–5 1–11 1–2 10–20 1–12 9–11
Diversity index 0.88 0.696 0.873 0.609 0.543 0.746 0.54 0.308 0.638 0.239
84 isolates from CDC and MSU Fragment range (nt) 106–254 253–295 270–372 387–452 135–210 255–394 175–278 105–213 210–307 405–422
No. of alleles 22 9 15 5 7 12 4 10 7 7
Null alleles (%) 4 49 0 6 1 39 31 76 52 6
Allelic range 2–26 2–9 4–21 8–12 0–7 1–17 1–16 3–20 1–12 7–11
Diversity index 0.791 0.717 0.895 0.585 0.529 0.791 0.538 0.396 0.558 0.262
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with epidemiological data and PFGE, these four loci could potentially be
combined in a single multiplex PCR reaction for rapid screening of iso-
lates in a STEC O26 outbreak investigation.
3.3.2. O111
Serogroup O111 had a low percentage of null alleles and the highest
loci diversity indices, even though little or no diversity was observed in
Table 7
Comparison of VNTR loci characteristics for six non-O157 STEC serogroups.
Serogroup VNTR locus
SVL-1 SVL-2 SVL-3 SVL-4 SVL-5 SVL-6 SVL-10 SVL-11 SVL-12 SVL-23
O26 Fragment range (nt) 131–254 259–295 288–318 451–452 169–170 256–336 175–176 132–133 288–289 416–418
No. of alleles 13 6 6 1 1 7 1 2 2 1
Null alleles (%) 0 0 0 0 0 7 0 93 93 0
Allelic range 6–26 2–8 7–12 12 2 1–10 1 7 10 9
Diversity index 0.989 0.769 0.868 0 0 0.802 0 0.143 0.143 0
O111 Fragment range (nt) 131–211 265–301 299–372 405–452 169–170 255–343 175–182 135–160 210–211 416–418
No. of alleles 7 6 8 3 1 6 3 6 3 1
Null alleles (%) 7 14 0 14 0 29 7 14 7 0
Allelic range 6–19 3–9 6–21 9–12 2 1–11 1–2 8–14 1–5 9
Diversity index 0.846 0.736 0.912 0.385 0 0.835 0.473 0.747 0.275 0
O103 Fragment range (nt) 112–118 264–266 282–318 405–452 135–210 341–394 175–176 105–106 210–211 416–418
No. of alleles 2 4 6 3 4 3 2 2 2 1
Null alleles (%) 0 71 0 7 7 79 21 93 36 0
Allelic range 3–4 2–4 6–12 9–12 0–5 11–17 1 3 1 9
Diversity index 0.143 0.495 0.868 0.473 0.396 0.385 0.363 0.143 0.495 0
O121 Fragment range (nt) 106–150 0 293–353 418–419 169–170 279–343 0 132–133 254–255 405–422
No. of alleles 5 1 6 2 1 4 1 2 2 6
Null alleles (%) 0 100 0 7 0 0 100 93 93 36
Allelic range 2–9 n/a 5–17 10 2 4–11 n/a 7 6 7–11
Diversity index 0.725 0 0.813 0.275 0 0.495 0 0.143 0.143 0.813
O45 Fragment range (nt) 112–113 0 288–305 387–452 180–197 0 175–176 0 210–211 416–418
No. of alleles 1 1 4 2 3 1 1 1 1 1
Null alleles (%) 0 100 0 0 0 100 0 100 0 0
Allelic range 3 n/a 6–10 8–12 4–7 n/a 1 n/a 1 9
Diversity index 0 0 0.648 0.143 0.582 0 0 0 0 0
O145 Fragment range (nt) 112–180 253–277 270–317 451–452 169–170 291–347 175–278 144–213 281–307 416–418
No. of alleles 4 4 5 2 1 4 3 3 3 1
Null alleles (%) 14 14 0 14 0 21 57 71 86 0
Allelic range 3–14 2–5 4–12 12 2 5–12 1–16 9–20 9–12 9
Diversity index 0.495 0.495 0.505 0.264 0 0.736 0.615 0.473 0.275 0
Fig. 1.Minimum spanning trees of (A) 24 non-O157 STEC isolates from the STEC Center at MSU and (B) 60 non-O157 STEC isolates from CDC constructed by BioNumerics using the
Manhattan coefficient. Each circle represents a single MLVA type with the size proportional to the number of isolates with that MLVA type. Numbers on branches indicate the number
of loci that vary between each MLVA type.
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five loci (SVL-4, SVL-5, SVL-10, SVL-12, and SVL-23). The remaining five
loci had a moderate to high level of diversity, ranging from 0.736 to
0.912 (Table 7). A total of 11 unique O111 MLVA types were observed,
with two groups of indistinguishable MLVA types. The three isolates
composing one of the groups were also indistinguishable by PFGE
using BlnI and XbaI, while the two isolates composing the other group
were distinguishable by PFGE.
3.3.3. O103
Serogroup O103 exhibited low to moderate diversity at most loci.
Only locus SVL-3 had a high diversity index of 0.868 and only loci SVL-
3, SVL-4, SVL-5, and SVL-12 were required to provide the observed
level of discrimination (Table 7). One pair of indistinguishable MLVA
types were observed among 13 unique MLVA types for the 14 isolates
tested. The two O103 isolates indistinguishable by MLVA, 2010C-3251
and 2010C-3219, were also indistinguishable by PFGE.
3.3.4. O121
Four loci exhibitedmoderate diversity in serogroup O121. Only SVL-
1, SVL-3, SVL-6, and SVL-23 were needed to provide the observed level
of discrimination (Table 7). Twelve unique MLVA types were observed
among the 14 O121 isolates. One group of 3 indistinguishable isolates
by MLVA was observed. Two of the three isolates (K5313 and K5316)
were also indistinguishable by PFGE with BlnI and XbaI.
3.3.5. O45
The lowest level of diversitywas observed among serogroupO45. No
PCR amplification was possible for loci SVL-2, SVL-6, and SVL-11 and no
Fig. 2. PFGE dendrogram of 60 clinical non-O157 STEC isolates from the CDC, generated by BioNumerics using categorical coefficient and UPGMA clustering.
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diversity was observed for loci SVL-1, SVL-10, SVL-12, and SVL-23
(Table 7). Among the 14 isolates tested, only six unique MLVA types
were observed with three groups of indistinguishable MLVA types.
The isolates constituting these groupswere not epidemiologically relat-
ed. However, two isolates indistinguishable by PFGE (K3472 and 3506-
04) were distinguishable by MLVA, differing by one tandem repeat at a
single locus (SVL-5).
3.3.6. O145
Low diversity indices were observed also for all ten loci among
serogroup O145. Although PCR amplification was possible at all loci,
no diversity was observed for 6 loci: SVL-1, SVL-2, SVL-4, SVL-5, SVL-
12, and SVL-23 (Table 7). Of 14 isolates tested, nine MLVA types were
observed with two groups of indistinguishable MLVA types. The first
group, isolates 4865/96 andGS-G5578620, isolated in Germany and Ne-
braska, respectively, were of different serotypes and had no logical epi-
demiological connection. The second group of indistinguishable O145
MLVA types consisted of isolates 2010C-3513, 2010C-3515, 2010C-
3507, 2010C-3526-1, and 2010C-3517. Three of these five isolates
(2010C-3513, 2010C-3515, and 2010C-3507) were also indistinguish-
able by PFGE.
3.4. Correlation of MLVA data with PFGE and epidemiological data.
3.4.1. 60 CDC isolates
Compared to PFGE, a similar level of discrimination was possible
with MLVA. While the total number of PFGE patterns (50) was slightly
higher than the number of MLVA types (45), the number of unique bac-
terial subtypes stayed the same for all serogroups except for O45 and
O145. Fifteen of the 58 clinical isolates from the CDC were outbreak re-
lated, and three of the four outbreaks with multiple isolates included
displayedmultiple PFGE patterns (Table 2).MLVA correctly grouped to-
gether isolates from two out of four outbreaks, although a sporadic iso-
latematched the outbreak pattern by both PFGE andMLVA in one of the
outbreaks (O121:H19). In the O145:NM outbreak, isolate 2010C-3508
differed from the other four isolates at MLVA loci SVL-11 and SVL-12
(Fig. 3), even though it was a PFGE match to the outbreak. In one of
the two O111:NM outbreaks, one isolate was different from the main
outbreak MLVA profile even though it was a PFGE match. In the second
O111:NM outbreak the two isolates included differed by PFGE but not
byMLVA. Only six MLVA profiles were detected among the ten sporadic
O45:H2 strains even though there were nine different PFGE patterns.
The two isolates matching by PFGE had different MLVA profiles.
3.4.2. 24 MSU isolates
All 24 non-O157 STEC isolates from the STEC Center at MSU had
unique PFGE patterns when XbaI was used, while 22 different MLVA
types were observed. Two O145 isolates (4865/96 and GS G5578620)
and two O45 isolates (MI01-88 and DA-21) were indistinguishable by
MLVAbut had noknown epidemiological connection andwere of differ-
ent serotypes.
4. Discussion
Successful identification and traceback of foodborne illness out-
breaks caused by bacterial pathogens requires bacterial subtyping tech-
niques that are highly discriminatory, reproducible, portable, objective,
versatile, and allow high throughput (Nadon et al., 2013). While MLVA
performs very well when assessed by these criteria, the method often
has a major weakness: versatility (Nadon et al., 2013). Most published
and well validated MLVA protocols are only useful for typing a subset
or a group of bacterial pathogens, such as a single serogroup or serotype
within a species. The discriminatory power and therefore the epidemi-
ological value ofMLVA is usually decreasedwhen a broad and highly di-
verse collection of strains from a bacterial species are targeted. Thus, the
versatility of MLVA is limited by its specificity. The value of MLVA is that
it allows evaluation of multiple relatively rapidly changing regions of a
bacterial genome, identifying minor differences among highly geneti-
cally similar strains. As a result, strains that are more distantly related
Fig. 3. Comparison of PFGE (left) andMLVA (right) for ten outbreak related and six sporadic non-O157 STEC isolates, comprising 6 groups of indistinguishable PFGE patterns by both XbaI
and BlnI. Only 2 of the 6 groups (isolates 3506-04 and K3472; isolates 2010C-3219 and 2010C-3251) were also indistinguishable by MLVA or clustered similarly.
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are not as efficiently typed and accurate evaluation of epidemiological
congruence might not be possible.
A single MLVA assay for multiple serogroups of pathogenic E. coli
that is comprised of a small enough number of VNTR loci to allow
rapid and routine strain typing of clinical and environmental/food
isolates while allowing better discrimination than the current gold
standard subtyping technique, PFGE, has been attempted previously
(Lindstedt et al., 2007; Izumiya et al., 2010; Løbersli et al., 2012). The
major limiting factor for further development of such assays may be
the lack of availability of closed genomes of clinically relevant E. coli
strains. Draft and partially assembled bacterial genome sequences do
not assemble accurately in repeat regions due to the short read length
produced by the predominant DNA sequencing technologies commonly
used and therefore do not allow optimal identification of candidate
VNTR loci for MLVA assay development. Additionally, MLVA may even-
tually go by the wayside as whole genome sequencing technologies are
becoming less expensive, potentially allowing whole genome compari-
sons of epidemiologically related isolates. However, MLVA is currently
still a valuable and highly discriminatory method that is commonly
used to augment PFGE data in foodborne illness outbreak investigations.
Non-O157 STEC serogroups have been isolated with increasing fre-
quency in recent years but no MLVA scheme for any non-O157 STEC
serogroups has yet been adopted for use by PulseNet. The purpose of
this studywas to investigate the possibility of developing a single, high-
ly discriminatory MLVA protocol for the six most commonly isolated
non-O157 STEC serogroups in theUnited States. Using all of the current-
ly available assembled non-O157 STEC genomes and whole genome
shotgun sequence contigs for non-O157 STEC strains deposited in
NCBI's GenBank database, ten VNTR loci were identified, allowing for
inter- and intra-serogroup strain discriminatory capability similar to
PFGE. While the number of non-O157 STEC isolates used in this study
was small, the relatively high congruence of MLVA, PFGE, and epidemi-
ological data for five of the six serogroups tested illustrates the potential
usefulness of the developed scheme, following further optimization.
Strain discrimination by the developedMLVA schemewas relatively
high among serogroups O26, O111, O103, and O121, with similar dis-
crimination to PFGE. Less strain discrimination than PFGEwas observed
for serogroups O45 and O145 even though the epidemiological concor-
dance was better than PFGE for O145:NM. Even in the available closed
genome sequences used for VNTR identification, O26, O111, and O103
exhibited more tandem repeat diversity than all four strains of O145.
While the whole genome shotgun contigs (wgs) database of NCBI was
searched with candidate VNTR flanking sequences identified among
the closed genomes, this only aided in optimal PCR primer design and
did not aid in identification of diverse VNTR loci (except for SVL-23,
which was only diverse in O121).
Among outbreak related isolates, the developed MLVA scheme dif-
ferentiated among few isolates with indistinguishable PFGE profiles,
which will complicate data interpretation. Conversely, several isolates
indistinguishable by MLVA were distinguishable by PFGE (Table 2).
This observation confirms that the maximum possible strain discrimi-
nation often requires the use of more than one bacterial subtyping
method. However, for surveillance epidemiological concordance is
more desirable instead of maximum strain discrimination. Much like
other MLVA protocols currently used by PulseNet, the developed
MLVA scheme could potentially be used to augment PFGE data for
non-O157 STEC isolates associated with foodborne illness outbreaks.
Since multiple serogroups were targeted in this study, potentially
highly diverse VNTR loci were chosen to aid in intra-serogroup discrim-
ination and potentially less diverse VNTR loci were chosen to aid in
inter-serogroup discrimination. Several loci exhibited little or no intra-
serogroup diversity but had distinct inter-serogroup diversity, helping
discriminate between serogroups (Table 7). For example, locus SVL-4
contained 12 tandem repeats in all 14 O26 isolates, nine tandem repeats
in 11 of 14 O111 isolates, and ten tandem repeats in 12 of 14 O121 iso-
lates. VNTR loci located on plasmids may also serve as useful serogroup
identifiers. Locus SVL-11was located on anO111 plasmid andwas high-
ly diverse among this serogroup. All chromosomally located VNTR loci
were contained within DNA sequences coding for known or putative
proteins (Table 4). It has been speculated that tandem repeat arrays
that are located within genes and having repeat lengths in multiples
of three, therefore not altering the open reading frame, are likely to be
more diverse than those located outside of gene sequences (Keys
et al., 2005). One of the selected VNTR loci (SVL-10) contained a tandem
repeat that was not amultiple of three. As expected, this locus exhibited
low overall diversity and only aided in the discrimination of one
serogroup (O145).
The genomic location of locus SVL-6was of special interest. Based on
a BLAST search against the NCBI database, SVL-6 was located within a
gene sharing high similarity to a stx2 converting phage (Smith et al.,
2012). Stx2 is one of themajor virulence factors of STEC and is frequent-
ly associated with the development of HUS (Nataro and Kaper, 1998). It
is believed that the stx2 gene can be acquired by E. coli following contact
with stx2 converting phages and subsequent incorporation of the se-
quence into previously non-pathogenic or less pathogenic E. coli
genomes (Scheutz et al., 2011; Grande et al., 2014). As expected, SVL-
6-specific PCR primers allowed amplification among serogroups O157,
O26, O111, O103, O121, and O145—the serogroups most commonly as-
sociated with Shiga toxin production—but not in 2 EPEC strains or in
E. coli K-12. However, the lack of amplification among serogroup O45
could not be explained but could be due to nucleotide polymorphisms
in the primer annealing location.
The developed prototype non-O157 STEC MLVA scheme is simple
and rapid with easy-to-interpret and portable results. Among the six
non-O157 STEC serogroups tested, the characteristics of the ten selected
VNTR loci varied considerably and it may be possible to tailor the devel-
oped MLVA scheme for each serogroup by retaining the most diverse
loci and discarding the least diverse. However, when typing all six
serogroups simultaneously, discarding any of the ten loci decreased
the inter-serogroup discriminatory capability. Unless more closed ge-
nome sequences are available for comparison, a higher overall level of
discrimination might not be possible. Before the developed prototype
MLVA scheme could be used to evaluate epidemiologically related iso-
lates, further extensive validation of the proposed method with a large
panel of outbreak related and sporadic isolates is necessary. The resul-
tant data should be compared to PFGE for all isolates to gain a more
complete understanding of the usefulness of this method for intra-
and inter-serogroup discrimination of epidemiologically related and
non-related non-O157 STEC isolates. Additionally, in order to deploy
the assay in multiple laboratories with different capillary electrophore-
sis platforms, a set of isolates with all ten VNTRs sequencedwill need to
be defined so that the fragment sizing data can be normalized to the ac-
tual sequenced copy number.
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